Novartis reported 8.91B in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Alcon AG ALC:SW 1.78B 90.98M
Amgen AMGN:US $ 5327M 250M
Artemis Alpha ATS:LN 78.1M 173.1M
AstraZeneca AZN:LN 789.49B 100.39B
Bayer BAYN:GR 18.39B 561M
Biogen BIIB:US $ 2003.5M 17.9M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Eli Lilly And LLY:US $ 7672.4M 133.3M
Fresenius FRE:GR € 8015M 32M
Galapagos GLPG:NA 64.06M 14.46M
Genmab GEN:DC 3.88B 689M
Gilead Sciences GILD:US $ 4118M 331M
GlaxoSmithKline GSK:LN 687B 192.7B
Hikma Pharmaceutical HIK:LN 73.35B 13.4B
Merck MRK:GR € 4867M 162M
Novartis NOVN:VX 8.91B 232M
Novartis NVS:US $ 8910M 232M
Orion ORNBV:FH 222M 9.9M
Recordati REC:IM 440.64M 32.96M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M